FeaturesSignalPricingFounders
Log inGet started free
ES

Elm Street Ventures

Micro VCActive

ESVC principal strategy is to create and initially operate life sciences companies founded on intellectual property developed at Yale

New Haven, United StatesFounded 2012elmvc.com/
18
Investments
6
Exits
—
AUM
33.3%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Elm Street Ventures.

Get started free

Investment Thesis & Strategy

Elm Street Ventures invests in biotech companies, specifically those founded on Yale University intellectual property, and may invest in fintech and venture capital at various stages.

Investment Activity

Deals per year over the last 10 years

1
2010
0
2011
0
2012
1
2013
2
2014
0
2015
2
2016
2
2017
1
2018
1
2019

Portfolio Companies

Selected investments from their portfolio of 18 companies

R
ReNetX Bio
Biotech · Series A, 2019
Active
R
Rallybio
Biotech · Series A, 2018
Active
X
X-Rx
Biotech · Seed, 2017
Active
G
Gracell Biotechnologies
Biotech · Series A, 2017
Active
T
Talaris Therapeutics
Biotech · Series A, 2016
Active
A
Apic Bio
Biotech · Series A, 2016
Active
B
Biohaven Pharmaceutical
Biotech · Growth, 2014
Active
V
Valerion Therapeutics
Biotech · Series A, 2014
Active
A
Arvinas
Biotech · Series A, 2013
Active
I
Immunovaccine
Biotech · Series A, 2010
Active

Frequently Asked Questions

Elm Street Ventures focuses on Seed, Series A stage investments.

Related Investors

LaunchCapital

New Haven, United States · 231 deals

SV Angel

San Francisco, United States · 922 deals

Right Side Capital Management

San Francisco, United States · 894 deals

Kima Ventures

Paris, France · 565 deals

Alumni Ventures Group

Manchester, United States · 442 deals

FundersClub

San Francisco, United States · 425 deals